PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	39.98	41.69	56.56	73.82	65.24	28.84
Cash & Short-Term Investments	39.98	41.69	56.56	73.82	65.24	28.84
Cash Growth	-40.00%	-26.29%	-23.38%	13.15%	126.23%	137.13%
Prepaid Expenses	2.49	3.36	2.49	2.66	1.6	1.5
Total Current Assets	42.47	45.05	59.06	76.48	66.84	30.34
Property, Plant & Equipment	0.29	0.3	0.34	0.53	0.36	0.55
Other Long-Term Assets	4.27	-	-	-	-	-
Total Assets	47.03	45.36	59.39	77.01	67.2	30.89
Accounts Payable	2.86	1.68	6.98	1.22	1.31	1.42
Accrued Expenses	2.85	2.84	2.42	8.31	2.19	1.74
Short-Term Debt	12.5	12.5	4.17	-	-	-
Current Portion of Leases	0.06	0.06	0.06	0.29	0.26	0.12
Total Current Liabilities	18.27	17.09	13.63	9.82	3.76	3.27
Long-Term Debt	6.35	9.2	19.51	23.02	-	-
Long-Term Leases	0.05	0.06	0.12	0.16	0.23	0.49
Total Liabilities	24.67	26.35	33.26	33.01	3.99	3.76
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	212.95	201.1	170.62	145.55	123.9	70.91
Retained Earnings	-190.6	-182.11	-144.5	-101.56	-60.7	-43.79
Shareholders' Equity	22.36	19	26.13	44	63.21	27.13
Total Liabilities & Equity	47.03	45.36	59.39	77.01	67.2	30.89
Total Debt	18.96	21.83	23.85	23.47	0.49	0.61
Net Cash (Debt)	21.02	19.86	32.71	50.35	64.75	28.23
Net Cash Growth	-50.58%	-39.28%	-35.03%	-22.25%	129.38%	132.12%
Net Cash Per Share	0.55	0.54	1.06	1.76	2.53	1.69
Filing Date Shares Outstanding	45.71	45.4	36.68	30.72	28.45	22.26
Total Common Shares Outstanding	45.45	37.99	33.09	30.17	28.45	22.26
Working Capital	24.2	27.97	45.43	66.66	63.08	27.07
Book Value Per Share	0.49	0.50	0.79	1.46	2.22	1.22
Tangible Book Value	22.36	19	26.13	44	63.21	27.13
Tangible Book Value Per Share	0.49	0.50	0.79	1.46	2.22	1.22
Machinery	-	0.3	0.27	0.12	0.12	0.12

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q